Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Methotrexate for Inflammation in HIV (A5314)
NCT01949116Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in cardiovascular disease (CVD), inflammation, sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2014; status: completed.
02
Drugs
methotrexate
03
Conditions
cardiovascular disease (CVD)inflammation
Beyond the preview
Go deeper on NCT01949116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949116.